News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rajangam Kanya
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/02/2023 |
4
| Rajangam Kanya (Chief Medical & Devt. Officer) has filed a Form 4 on Senti Biosciences, Inc.|
Txns:
| Granted 130,000 options to buy
@ $1.81, valued at
$235.3k
|
|
| 07/20/2022 |
4
| Rajangam Kanya (Chief Medical & Devt. Officer) has filed a Form 4 on Senti Biosciences, Inc.|
Txns:
| Granted 327,750 options to buy
@ $1.8, valued at
$590k
|
|
| 07/15/2022 |
3
| Rajangam Kanya (Chief Medical & Devt. Officer) has filed a Form 3 on Senti Biosciences, Inc. |
| 01/19/2022 |
4
| Rajangam Kanya (Chief Medical Officer) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Granted 12,800 shares
@ $0
Granted 76,800 options to buy
@ $12.14, valued at
$932.4k
|
|
| 08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2020 |
3
| Rajangam Kanya (Chief Medical Officer) has filed a Form 3 on Nkarta, Inc. |
|
|